MOBILion Systems

MOBILion Systems Advances Disease Diagnosis and Treatment by Commercializing Instruments that Enhance Multi-Omics Disease, Drug, and Biomarker Discovery. Strengthening complementary research in genomics provides a better understanding of disease mechanisms and drug targets, paving the way for early disease detection, more accurate diagnoses, improved treatment options for individual patients, and reduced healthcare costs.MOBILion's instruments offer unprecedented speed, sensitivity, and resolution to rapidly detect clinically relevant molecules such as proteins, peptides, metabolites, lipids, and more, enabling better prediction, diagnosis, and treatment of diseases. MOBILion’s instruments process population-scale samples in days rather than years and detect low-abundance molecules unseen by existing instruments, providing researchers and clinicians with greater confidence in clinical outcomes.